【SciClone】April 2026 Monthly Revenue: 0.63 Billion (YoY +0.1%)
Key facts
- 【SciClone】April 2026 Monthly Revenue: 0.63 Billion (YoY +0.1%)
- SciClone announced its monthly revenue for April 2026 was 0.63 billion NTD, marking a 0.1% increase compared to the same month last year. This indicates stable performance for the company in the biotechnology and medical industry.
- Source: PR Times
- Date: April 1, 2026
Direct answer
SciClone announced its monthly revenue for April 2026 was 0.63 billion NTD, marking a 0.1% increase compared to the same month last year. This indicates stable performance for the company in the biotechnology and medical industry.
- Citation
- 【SciClone】April 2026 Monthly Revenue: 0.63 Billion (YoY +0.1%) (April 1, 2026), PR Times
- Source
- PR Times
- Date
- April 1, 2026
SciClone announced its monthly revenue for April 2026 was 0.63 billion NTD, marking a 0.1% increase compared to the same month last year. This indicates stable performance for the company in the biotechnology and medical industry.
📋 Article Processing Timeline
- 📰 Published: April 1, 2026 at 09:00
- 🔍 Collected: May 12, 2026 at 08:00 (983h 0m after Published)
- 🤖 AI Analyzed: May 12, 2026 at 17:04 (9h 4m after Collected)
Company Name: SciClone
Industry: Biotechnology and Medical Industry
Data Month: April 2026
Monthly Revenue: 63,232 thousand NTD (0.63 billion NTD)
Year-on-year change from last month: +0.1%
FAQ
What are the key facts in this article?
SciClone announced its monthly revenue for April 2026 was 0.63 billion NTD, marking a 0.1% increase compared to the same month last year. This indicates stable performance for the company in the biotechnology and medical industry.
What is the direct answer?
SciClone announced its monthly revenue for April 2026 was 0.63 billion NTD, marking a 0.1% increase compared to the same month last year. This indicates stable performance for the company in the biotechnology and medical industry.
What is the source and date?
PR Times: https://openapi.twse.com.tw/revenue/twse-rev-1786-11504 | April 1, 2026